Niranjan Rao
5Patents
1h-index
20Co-inventors
47Inventor score
Filing activity: Jun 16, 2005 → Feb 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8039009B2 | Modified release formulations of memantine oral dosage forms | Emerging Cross-Sectional Technologies | 57 | Active |
| US10695296B2 | Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient | Chemistry; Metallurgy | 0 | Active |
| US10660868B2 | Modified release formulations of memantine oral dosage forms | Emerging Cross-Sectional Technologies | 0 | Active |
| US12036224B2 | Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredient | Human Necessities | 0 | Active |
| US8834924B2 | Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.